The FDA issued a safety announcement regarding the use of erythropoiesis-stimulating agents (ESAs) in 2010 with the recommendation that:
1. ESAs no longer be prescribed to patients with chronic renal failure
2. The risk of tumor development be explained to cancer patients on ESA therapy
3. Patients should no longer receive ESA therapy to prepare for allogenic transfusions
4. ESAs be prescribed only to patients younger than age 60 years
___
2
You might also like to view...
The nurse is presenting an educational event about vaccines at a local elementary school. When talking about vaccines, the nurse explains they are generally contraindicated in what situations?
A) In people who have renal impairment B) In people who have hepatic failure C) In people who are immunosuppressed D) In people who are over 65
A nursing instructor is describing the importance of preventing errors in medication administration and doses. Which of the following would the instructor emphasize as the best method for detecting errors?
A) Checking calculations three times B) Having each person involved in the process check the dosage C) Reading drug labels very carefully D) Checking the dosage in a reputable drug reference
A client post back surgery has called for the nurse on the call bell to change position. The nurse knows that the best method for assisting the client is to have the client:
a. sit upright from a back lying position b. log roll to turn onto the side c. use the trapeze to pull himself up d. twist the upper body to reach side rail
The school nurse suspects a testicular torsion in a young adolescent student. What action should the nurse take?
a. Place a warm moist pack on the scrotal area. b. Instruct the adolescent to lie down and elevate the legs. c. Refer the adolescent for immediate medical evaluation. d. Suggest that the adolescent wear a scrotum-protecting guard.